Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.

The Journal of Clinical Psychiatry
Arusha Farahani, Christoph U Correll

Abstract

To perform a meta-analysis of antidepressant-antipsychotic cotreatment versus antidepressant or antipsychotic monotherapy for psychotic depression. We performed an electronic search (from inception of databases until February 28, 2011) in PubMed/MEDLINE, Cochrane Library, and PsycINFO, without language or time restrictions. Search terms were (psychosis OR psychotic OR hallucinations OR hallucinating OR delusions OR delusional) AND (depression OR depressed OR major depressive disorder) AND (random OR randomized OR randomly). Eight randomized, placebo-controlled acute-phase studies in adults (N = 762) with standardized criteria-defined psychotic depression (including Research Diagnostic Criteria, DSM-III, DSM-IV, or ICD-10) were meta-analyzed, yielding 10 comparisons. Antidepressant-antipsychotic cotreatment was compared in 5 trials with 6 treatment arms (n = 337) with antidepressant monotherapy and in 4 trials with 4 treatment arms (n = 447) with antipsychotic monotherapy. Primary outcome was study-defined inefficacy; secondary outcomes included all-cause discontinuation, specific psychopathology ratings, and side effects. Using random effects models, we calculated relative risk (RR) with 95% confidence intervals (CIs), number-n...Continue Reading

Citations

Sep 1, 2012·Current Psychiatry Reports·Erik B Nelson
Jul 3, 2013·Asian Journal of Psychiatry·Massimiliano BuoliAlfredo Carlo Altamura
Oct 2, 2012·Journal of Affective Disorders·Anne Katrine K LeadholmSøren Dinesen Ostergaard
Jan 3, 2014·Acta Neuropsychiatrica·S D OstergaardA J Rothschild
Apr 20, 2013·Schizophrenia Bulletin·Anthony J Rothschild
Jan 29, 2013·BMC Psychiatry·Alastair J FlintUNKNOWN STOP-PD II Study Group
Jul 31, 2012·BMC Research Notes·Priya Gandhi, Amin Muhammad Gadit
Apr 24, 2013·Journal of Clinical Psychopharmacology·Daniel M BlumbergerBarnett S Meyers
Oct 12, 2013·Postgraduate Medicine·Mehrul Hasnain, W Victor R Vieweg
Feb 6, 2014·Expert Opinion on Drug Metabolism & Toxicology·Edoardo Spina, Jose de Leon
Jun 29, 2014·Expert Opinion on Drug Safety·Mario A Cristancho, Michael E Thase
Sep 4, 2015·Harvard Review of Psychiatry·Mark A ColijnGeorge T Grossberg
Oct 27, 2015·Journal of Affective Disorders·Søren D ØstergaardBarnett S Meyers
Sep 6, 2014·International Journal of Geriatric Psychiatry·Rossetos GournellisRobert Howard
Jun 27, 2013·Acta Psychiatrica Scandinavica·S D ØstergaardUNKNOWN STOP-PD Study Group
Apr 23, 2014·Journal of Affective Disorders·Romain IcickJean-Pierre Lépine
Jul 10, 2013·European Journal of Pharmacology·Andrea de BartolomeisCarmine Tomasetti
Nov 21, 2014·PloS One·Bart P de KwaastenietDamiaan Denys
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
Aug 4, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sagar V ParikhUNKNOWN CANMAT Depression Work Group
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jaap WijkstraWillem A Nolen
Dec 26, 2018·Acta Psychiatrica Scandinavica·A Bayes, G Parker
Mar 1, 2018·The British Journal of Psychiatry : the Journal of Mental Science·M Heslin, A H Young
Jun 28, 2019·Bipolar Disorders·Gin S Malhi, Erica Bell
Aug 26, 2014·Journal of Clinical Psychopharmacology·Inmaculada BaezaJosefina Castro-Fornieles
Aug 12, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·I BaryshnikovE Isometsä
Aug 28, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Gustavo H Vázquez
Aug 21, 2019·JAMA : the Journal of the American Medical Association·Alastair J FlintUNKNOWN STOP-PD II Study Group
Aug 21, 2019·JAMA : the Journal of the American Medical Association·William H Coryell
Jul 1, 2018·Acta Psychiatrica Scandinavica·K S BinghamUNKNOWN STOP-PD Study Group
Feb 16, 2021·Journal of Clinical Psychopharmacology·Dina A PatelUNKNOWN STOP-PD II Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here